Dangerous Diabetes Drugs: Victoza
Novo Nordisk Seeks New Uses for Victoza
Novo Nordisk’s Chief Science Officer Mads Krogsgaard Thomsen stated that the pharmaceutical company is looking into continuing trials to determine if Victoza could be marketed as a possible Alzheimer’s treatment. Victoza is currently going through a proof of concept study. If this is successful, the drug will continue through phase III clinical trials to see…
Incretin Mimetic Drug Lawsuits Consolidated in Federal Court
On August 28, 2013, it was announced that litigation involving incretin mimetic drugs Byetta, Victoza, Januvia, and Janumet are being consolidated into multi-district litigation in California federal court. Usually lawsuits against different companies, as is in this case, are not consolidated into one MDL. In this case however, many of the plaintiffs bringing the lawsuits…
Novo Nordisk Looking To Get Victoza Approved for Weight Loss
In April 2013, results from Novo Nordisk’s clinical trial of diabetes drug Victoza showed that the drug can help obese people lose weight. The FDA has not yet granted Novo Nordisk approval for this indication, but with further studies planned, they hope to do so soon. Both diabetes and insulin can cause weight gain,…
Public Citizen Calls for Victoza to be Banned by FDA
On April 19 of 2012, the watchdog group Public Citizen called for the FDA to remove Novo Nordisk’s Victoza (liraglutide) from the market. Their reasoning? Without any real benefit, the drug has major risks, namely thyroid tumors and cancer. In its petition, the group states: “No information concerning the mechanism for this tumor-inducing effect…
Victoza Complications
Victoza is a once daily, injectable medication used to treat type 2 diabetes by increasing the amount of insulin the body produces. The drug’s name is liraglutide, and it belongs to the GLP-1 agonist class of drugs. Manufactured by Novo Nordisk, it was approved by the FDA in 2010. There has been a lot of…
